ContextPrenatal magnesium sulfate may reduce the risk of cerebral palsy or death in very
preterm infants. ObjectiveTo determine the effectiveness of magnesium sulfate given for …

Background: Antenatal magnesium sulfate can potentially reduce the risk of cerebral palsy
in neonates delivered between 24 and 32 weeks of gestational age. Some studies using …

Background: labour is a stressful event for the fetus but is well tolerated by most fetuses.
However, in some infants stress of labour in terms of metabolic acidosis can lead to Hypoxic …

Three large, randomized placebo-controlled trials of antenatal MgSO 4 for fetal
neuroprotection have been conducted; separately and together, they demonstrate that …

Background Epidemiological and basic science evidence suggests that magnesium
sulphate before birth may be neuroprotective for the fetus. Objectives To assess the effects …

Objectives: To determine the role of magnesium sulphate given for fetal neuro protection to
women at risk of preterm birth in preventing neonatal mortality and neuro developmental …

Background Magnesium sulfate is an accepted intervention for fetal neuroprotection. There
are some perceived differences in the international recommendations on the use …

OBJECTIVE: To evaluate the association of duration of magnesium sulfate infusion with
stillbirth or death, cerebral palsy, and select adverse maternal and neonatal outcomes …

Society for Maternal-Fetal Medicine) have focused on the major obstetric controversy of
whether to use magnesium sulfate (MgSO4) in women likely to deliver preterm to prevent …

The aim of our study was to assess the feasibility of implementing a protocol for the use of
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …